Pfizer (NYSE:PFE) and Lpath reached an agreement in 2010 which provides the former an exclusive option for a global license through which to develop and commercialize iSonep. Lpath has initiated the dosing of iSonep in its Nexus Phase 2 study, with several wet-AMD patients treated since Sept. 21st. Lpath plans to dose 160 subjects who have not responded completely to a VEGF inhibitor in the double-blind, multi-site trial, and has also worked with Pfizer extensively on design and goals of the Nexus Phase 2 evaluation.
Verizon Communications (NYSE:VZ): Telefonica Global Solutions and Verizon Enterprise Solutions are partnering so that Verizon Immersive Video Exchange and Telefonica Global Telepresence Exchange customers can work together through Cisco TelePresence to meet the rising demand for video meetings. Currently, businesses and government agencies using either firm’s video meeting system can increase their “collaboration pool” and meet face-to-face across more video-enabled locations globally for enhanced productivity and business efficiency.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Target Corporation (NYSE:TGT): Stephanie Lucy, Target Corporation’s (NYSE:TGT) vice president of toys, forecasts that consumers shopping for holiday toys will scan, purchase and ship them while in the stores, according to Reuters. Along with adding hundreds of exclusive items to drive sales, on October 14th, the stores will feature 20 toys at the front of their aisles promoted with signs featuring QR codes; shoppers equipped with smart phones can scan the codes to purchase any of those items and have them shipped free of charge.